Your browser doesn't support javascript.
loading
Interim [18F]Fluorodeoxyglucose-Positron Emission Tomography During Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
Hindié, Elif; Groheux, David.
Affiliation
  • Hindié E; Elif Hindié, MD, PhD, Bordeaux University Hospital, Bordeaux, France; and David Groheux, MD, PhD, Saint-Louis Hospital, Paris, France.
  • Groheux D; Elif Hindié, MD, PhD, Bordeaux University Hospital, Bordeaux, France; and David Groheux, MD, PhD, Saint-Louis Hospital, Paris, France.
J Clin Oncol ; 37(23): 2091-2092, 2019 08 10.
Article in En | MEDLINE | ID: mdl-31251692
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Limits: Humans Language: En Journal: J Clin Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Limits: Humans Language: En Journal: J Clin Oncol Year: 2019 Document type: Article Affiliation country: France Country of publication: United States